IronSources Challenge to Mobile App-Installation Patent Tossed

Tuesday, April 7, 2026iiplaeditorialSource: IIPLA
ironsources-challenge-to-mobile-app-inst.png
Source attribution
Image: Image courtesy of iipla.org

IronSource’s Challenge to Mobile App-Installation Patent Tossed

By Editorial Team

IronSource Ltd., a mobile gaming company, has been denied the opportunity to appeal an administrative tribunal's decision that allowed competitor Digital Turbine Inc. to modify aspects of a patent related to the installation process of mobile apps, as per the Federal Circuit's ruling.

The Federal Circuit stated that IronSource failed to demonstrate that it or its customers faced a significant risk of being sued for infringing the altered patent, thus lacking the necessary standing to proceed with the case.

In 2021, IronSource contested Digital Turbine's US Patent No. 11,157,256 at the Patent Trial and Appeal Board, arguing that it was either anticipated, obvious, or both. In March 2024, the tribunal sided with IronSource. However, simultaneously, the US Patent...

To access more details on this legal matter, visit Bloomberg Law for further insights and analysis.

© 2026 Bloomberg Industry Group, Inc. All Rights Reserved

Related Coverage

Continue in the newsroom

Back to newsroom
IP News

Purple Rain Co-Star Ends Apollonia Trademark Rights Suit

‘Purple Rain’ Co-Star Ends ‘Apollonia’ Trademark Rights Suit By Editorial Team Patty Apollonia Kotero, known for her role as Prince’s co-star in the iconic 1984 film “Purple Rain,” has decided to drop her lawsuit agai...

Thursday, April 9, 2026
IP News

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct By Editorial Team A Houston-based patent attorney faced a tough Federal Circuit bench while seeking to wipe out a $207,000 sanction against him and his clie...

Thursday, April 9, 2026
IP News

J&J Defends Blood-Clotting Powder IP From Baxter Attack

J&J Defends Blood-Clotting Powder IP From Baxter Attack By Editorial Team A subsidiary of Johnson & Johnson has successfully defended its patent for a hemostatic powder used to treat bleeding against objections from B...

Thursday, April 9, 2026